Clinical Trials Browser

Neoplasms × Immune Checkpoint Inhibitors × Sarcoma × Clear all

NCT03425279 2025-09-23

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

Phase 1/2 Completed

Neoplasms, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

NCT04673942 2024-10-26

BETA-PRIME

Phase 2 Recruiting

Adenoviridae Infections, Chondrosarcoma, Neoplasms, Sarcoma